Bile Duct Risk Factors

A risk factor is anything that affects your chance of getting a disease like cancer. Different cancers have different risk factors. Some risk factors, like smoking, can be changed. Others, like a person’s age or family history, can’t be changed.

But having a risk factor, or even many risk factors, does not mean that a person will get the disease. And many people who get the disease have few or no known risk factors.

Researchers have found some risk factors that make a person more likely to develop bile duct cancer.

Certain diseases of the liver or bile ducts

People who have chronic (long-standing) inflammation of the bile ducts have an increased risk of developing bile duct cancer. Certain conditions of the liver or bile ducts can cause this, these include:

  • Primary sclerosing cholangitis (PSC), a condition in which inflammation of the bile ducts (cholangitis) leads to the formation of scar tissue (sclerosis). People with PSC have an increased risk of bile duct cancer. The cause of the inflammation is not usually known. Many people with this disease also have inflammation of the large intestine, called ulcerative colitis.
  • Bile duct stones, which are a lot like but much smaller than gallstones, can also cause inflammation that increases the risk of bile duct cancer.
  • Choledochal cyst disease, a rare condition some people are born with. It causes bile-filled sacs along the bile ducts. (Choledochal means having to do with the common bile duct.) If not treated, the bile sitting in these sacs causes inflammation of the duct walls. The cells of the duct wall often have areas of pre-cancerous changes, which, over time, cam progress to bile duct cancer.
  • Liver fluke infections, which occur in some Asian countries when people eat raw or poorly cooked fish that are infected with these tiny parasite worms. In humans, these flukes live in the bile ducts and can cause bile duct cancer. There are several types of liver flukes. The ones most closely related to bile duct cancer risk are Clonorchis sinensis and Opisthorchis viverrini. Liver fluke infection is rare in the US, but it can affect people who travel to Asia.
  • Abnormalities where the bile duct and pancreatic duct normally meet which can allow digestive juices from the pancreas to reflux (flow back) into the bile ducts. This backward flow keeps the bile from moving through the bile ducts the way it should. People with these abnormalities are at higher risk of bile duct cancer.
  • Cirrhosis, which is damage to the liver caused by scar tissue. It's caused by irritants like alcohol and diseases like hepatitis. Studies have found it raises the risk of bile duct cancer.
  • Infection with hepatitis B virus or hepatitis C virus which increases the risk of intrahepatic bile duct cancers. This may be at least in part because long-term infections with these viruses can also lead to cirrhosis.

Other rare diseases of the liver and bile duct that may increase the risk of developing bile duct cancer include polycystic liver disease and Caroli syndrome (a dilation of the intrahepatic bile ducts present at birth).

Inflammatory bowel disease

Inflammatory bowel disease includes ulcerative colitis and Crohn’s disease. People with these diseases have an increased risk of bile duct cancer.

Older age

Older people are more likely than younger people to get bile duct cancer. Most people diagnosed with bile duct cancer are in their 60s or 70s.

Ethnicity and geography

In the US, the risk of bile duct cancer is highest among Hispanic Americans. Worldwide, bile duct cancer is much more common in Southeast Asia and China, largely because of the high rate of infection with liver flukes in these areas.

Obesity

Being overweight or obese can increase the risk of cancers of the gallbladder and bile ducts. This could be because obesity increases the risk of gallstones and bile duct stones, as well as the risk of non-alcoholic fatty liver disease. But there may be other ways that being overweight can lead to bile duct cancers, such as changes in certain hormones.

Non-alcoholic fatty liver disease

Non-alcoholic fatty liver disease is the build-up of extra fat in the liver cells that's not caused by alcohol. Over time, this can cause swelling and scarring that can progress to cancer.

Exposure to Thorotrast

A radioactive substance called Thorotrast (thorium dioxide) was used as a contrast agent for x-rays until the 1950s. It was found to increase the risk for bile duct cancer, as well as some types of liver cancer, and is no longer used.

Family history

A history of bile duct cancer in the family seems to increase a person’s chances of developing this cancer, but the risk is still low because this is a rare disease. Most bile duct cancers are not found in people with a family history of the disease.

Diabetes

People with diabetes (type 1 or type 2) have a higher risk of bile duct cancer. This increase in risk is not high, and the overall risk of bile duct cancer in someone with diabetes is still low.

Alcohol

People who drink alcohol are more likely to get intrahepatic bile duct cancer. The risk is higher in those who have liver problems from drinking alcohol.

Other possible risk factors

Studies have found other factors that might increase the risk of bile duct cancer, but the links are not as clear. These include:

  • Smoking
  • Chronic pancreatitis (long-term inflammation of the pancreas)
  • Infection with HIV (the virus that causes AIDS)
  • Exposure to asbestos
  • Exposure to radon or other radioactive chemicals
  • Exposure to dioxin, nitrosamines, or polychlorinated biphenyls (PCBs)

The American Cancer Society medical and editorial content team

Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Abou-Alfa GK, Jarnagin W, Lowery M, D’Angelica M, Brown K, Ludwig E, Covey A, Kemeny N, Goodman KA, Shia J, O’Reilly EM. Liver and bile duct cancer. In: Neiderhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, PA. Elsevier; 2014:1373-1395.

American Liver Foundation. Non-Alcoholic Fatty Liver Disease. Accessed at https://liverfoundation.org/for-patients/about-the-liver/diseases-of-the-liver/non-alcoholic-fatty-liver-disease/#information-for-the-newly-diagnosed on June 18, 2018.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. v.1.2018. Accessed at www.nccn.org/professionals/physician_gls/pdf/hepatobiliary.pdf on June 19, 2018.

Patel T, Borad MJ. Carcinoma of the biliary tree. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, PA. Lippincott Williams & Wilkins; 2015:715-735.

Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The Liver Cancer Pooling Project. Br J Cancer. 2018;118(7):1005-1012.

Petrick JL, Yang B, Altekruse SF, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. PLoS One. 2017:12(10).

Welzel TM, Graubard BI, El-Serag HB, et al. Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: a population-based case-control study. Clin Gastroenterol Hepatol. 2007;5(10):1221-1228.  

Last Revised: July 3, 2018

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.

Causes, Risk Factors, and Prevention